These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
145 related articles for article (PubMed ID: 9811164)
21. Mechanisms of glucose transport at the blood-brain barrier: an in vitro study. McAllister MS; Krizanac-Bengez L; Macchia F; Naftalin RJ; Pedley KC; Mayberg MR; Marroni M; Leaman S; Stanness KA; Janigro D Brain Res; 2001 Jun; 904(1):20-30. PubMed ID: 11516408 [TBL] [Abstract][Full Text] [Related]
22. Choline uptake by mouse brain capillary endothelial cells in culture. Sawada N; Takanaga H; Matsuo H; Naito M; Tsuruo T; Sawada Y J Pharm Pharmacol; 1999 Jul; 51(7):847-52. PubMed ID: 10467961 [TBL] [Abstract][Full Text] [Related]
23. Transport mechanism of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors at the blood-brain barrier. Tsuji A; Saheki A; Tamai I; Terasaki T J Pharmacol Exp Ther; 1993 Dec; 267(3):1085-90. PubMed ID: 8263769 [TBL] [Abstract][Full Text] [Related]
24. In vivo evidence for the efflux transport of pentazocine from the brain across the blood-brain barrier using the brain efflux index method. Moriki Y; Suzuki T; Furuishi T; Fukami T; Tomono K; Watanabe J J Drug Target; 2005 Jan; 13(1):53-9. PubMed ID: 15848954 [TBL] [Abstract][Full Text] [Related]
25. Efflux of taurocholic acid across the blood-brain barrier: interaction with cyclic peptides. Kitazawa T; Terasaki T; Suzuki H; Kakee A; Sugiyama Y J Pharmacol Exp Ther; 1998 Aug; 286(2):890-5. PubMed ID: 9694947 [TBL] [Abstract][Full Text] [Related]
26. Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier. Ose A; Kusuhara H; Endo C; Tohyama K; Miyajima M; Kitamura S; Sugiyama Y Drug Metab Dispos; 2010 Jan; 38(1):168-76. PubMed ID: 19833843 [TBL] [Abstract][Full Text] [Related]
27. Involvement of P-glycoprotein in blood-brain barrier transport of pentazocine in rats using brain uptake index method. Moriki Y; Suzuki T; Fukami T; Hanano M; Tomono K; Watanabe J Biol Pharm Bull; 2004 Jun; 27(6):932-5. PubMed ID: 15187451 [TBL] [Abstract][Full Text] [Related]
28. Involvement of organic anion transporters in the efflux of uremic toxins across the blood-brain barrier. Deguchi T; Isozaki K; Yousuke K; Terasaki T; Otagiri M J Neurochem; 2006 Feb; 96(4):1051-9. PubMed ID: 16445853 [TBL] [Abstract][Full Text] [Related]
29. Brain to blood efflux transport of adenosine: blood-brain barrier studies in the rat. Isakovic AJ; Abbott NJ; Redzic ZB J Neurochem; 2004 Jul; 90(2):272-86. PubMed ID: 15228584 [TBL] [Abstract][Full Text] [Related]
30. ATA2 is predominantly expressed as system A at the blood-brain barrier and acts as brain-to-blood efflux transport for L-proline. Takanaga H; Tokuda N; Ohtsuki S; Hosoya K; Terasaki T Mol Pharmacol; 2002 Jun; 61(6):1289-96. PubMed ID: 12021389 [TBL] [Abstract][Full Text] [Related]
31. Contribution of organic anion transporter 3 (Slc22a8) to the elimination of p-aminohippuric acid and benzylpenicillin across the blood-brain barrier. Kikuchi R; Kusuhara H; Sugiyama D; Sugiyama Y J Pharmacol Exp Ther; 2003 Jul; 306(1):51-8. PubMed ID: 12684544 [TBL] [Abstract][Full Text] [Related]
32. In vitro and in vivo transport of zidovudine (AZT) across the blood-brain barrier and the effect of transport inhibitors. Masereeuw R; Jaehde U; Langemeijer MW; de Boer AG; Breimer DD Pharm Res; 1994 Feb; 11(2):324-30. PubMed ID: 8165196 [TBL] [Abstract][Full Text] [Related]
33. Role of blood-brain barrier organic anion transporter 3 (OAT3) in the efflux of indoxyl sulfate, a uremic toxin: its involvement in neurotransmitter metabolite clearance from the brain. Ohtsuki S; Asaba H; Takanaga H; Deguchi T; Hosoya K; Otagiri M; Terasaki T J Neurochem; 2002 Oct; 83(1):57-66. PubMed ID: 12358729 [TBL] [Abstract][Full Text] [Related]
34. Blood-brain barrier transport of naloxone does not involve P-glycoprotein-mediated efflux. Suzuki T; Miyata M; Zaima C; Furuishi T; Fukami T; Kugawa F; Tomono K J Pharm Sci; 2010 Jan; 99(1):413-21. PubMed ID: 19530072 [TBL] [Abstract][Full Text] [Related]
35. Human immunodeficiency virus type 1 transport across the in vitro mouse brain endothelial cell monolayer. Nakaoke R; Ryerse JS; Niwa M; Banks WA Exp Neurol; 2005 May; 193(1):101-9. PubMed ID: 15817268 [TBL] [Abstract][Full Text] [Related]
36. Blood-brain barrier produces significant efflux of L-aspartic acid but not D-aspartic acid: in vivo evidence using the brain efflux index method. Hosoya K; Sugawara M; Asaba H; Terasaki T J Neurochem; 1999 Sep; 73(3):1206-11. PubMed ID: 10461913 [TBL] [Abstract][Full Text] [Related]
37. Characterization of the L-glutamate clearance pathways across the blood-brain barrier and the effect of astrocytes in an in vitro blood-brain barrier model. Helms HC; Aldana BI; Groth S; Jensen MM; Waagepetersen HS; Nielsen CU; Brodin B J Cereb Blood Flow Metab; 2017 Dec; 37(12):3744-3758. PubMed ID: 28145808 [TBL] [Abstract][Full Text] [Related]
38. Limited distribution of new quinolone antibacterial agents into brain caused by multiple efflux transporters at the blood-brain barrier. Tamai I; Yamashita J; Kido Y; Ohnari A; Sai Y; Shima Y; Naruhashi K; Koizumi S; Tsuji A J Pharmacol Exp Ther; 2000 Oct; 295(1):146-52. PubMed ID: 10991972 [TBL] [Abstract][Full Text] [Related]
39. Rat organic anion transporter 3 (rOAT3) is responsible for brain-to-blood efflux of homovanillic acid at the abluminal membrane of brain capillary endothelial cells. Mori S; Takanaga H; Ohtsuki S; Deguchi T; Kang YS; Hosoya K; Terasaki T J Cereb Blood Flow Metab; 2003 Apr; 23(4):432-40. PubMed ID: 12679720 [TBL] [Abstract][Full Text] [Related]
40. Study on brain interstitial fluid distribution and blood-brain barrier transport of baclofen in rats by microdialysis. Deguchi Y; Inabe K; Tomiyasu K; Nozawa K; Yamada S; Kimura R Pharm Res; 1995 Dec; 12(12):1838-44. PubMed ID: 8786954 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]